MX1 and myeloid sarcoma: A potentially beneficial effect of an elevated endogenous type I IFN response was also reported by Hesse et al. [33], who described a positive correlation of MX1 expression and IL-10 expression, and a negative correlation of IL-10 expression and disease activity on magnetic resonance imaging in untreated MS patients.